|
Market Closed -
Euronext Paris
11:55:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.8980 EUR | +7.16% |
|
-3.44% | +50.67% |
| 09-04 | Biosynex: creditors to vote on financial safeguard plan | |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact |
Business description: Biosynex

- manufacturing of diagnosis tests for own account;
- sale of diagnosis tests supplied by other manufacturers of semi-finished products;
- research and development services for third party;
- sale of licenses;
- sale of biological reagents.
Number of employees: 397
Sales by Activity: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Sale of Merchandise | 175M | 99.36M | 52.09M | 42.94M | 39.47M |
Products Sold | 44.06M | 29.86M | 15.39M | 24.63M | 25.21M |
Services Sold | 18.58M | 9.39M | 2.37M | 1.89M | 1.52M |
Unallocated Immobilised Production | 525K | 672K | 1.35M | 911K | 528K |
Unallocated Operating Grants | 436K | 282K | - | - | - |
Geographical breakdown of sales: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
France | 194M | 120M | 52.5M | 52.82M | 49.26M |
Export | 189M | 76.4M | 40.4M | 48.35M | 45.93M |
Executive Committee: Biosynex
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 2015-06-23 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Biosynex
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 2015-06-23 |
Thomas Lamy
BRD | Director/Board Member | - | 2015-06-23 |
Larry Abensur
CHM | Chairman | 71 | 2015-06-23 |
Elie Fraenckel
BRD | Director/Board Member | - | 2012-10-31 |
Brigitte Geny
BRD | Director/Board Member | - | 2024-06-06 |
Diane Abensur
BRD | Director/Board Member | - | 2024-06-06 |
Company details: Biosynex
Biosynex SA
22, boulevard Sebastien Brant
67400, Illkirch-Graffenstaden
+33 3 88 78 78 87
http://www.biosynex.com
Group companies: Biosynex
| Name | Category and Sector |
|---|---|
Biosynex Swiss SA |
Diagnostic & Testing Substances
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.16% | -3.44% | +34.03% | -90.79% | 18.63M | ||
| +0.84% | -3.74% | -27.56% | +1.79% | 169B | ||
| -0.07% | -2.55% | -11.59% | +12.86% | 110B | ||
| +0.90% | +1.13% | -25.66% | +3.60% | 106B | ||
| -1.24% | -0.76% | -49.50% | -12.08% | 73.87B | ||
| -0.24% | +0.69% | +2.08% | +71.44% | 58.98B | ||
| -0.86% | +2.96% | +12.91% | +61.58% | 51.28B | ||
| -0.71% | -3.82% | -8.68% | -31.71% | 48.16B | ||
| +0.12% | -0.17% | -17.87% | +21.91% | 40.84B | ||
| -1.01% | -1.45% | +27.31% | -6.14% | 32.21B | ||
| Average | +0.49% | -1.12% | -6.45% | +3.24% | 69.02B | |
| Weighted average by Cap. | +0.03% | -1.30% | -17.07% | +11.23% |
- Stock Market
- Stocks
- ALBIO Stock
- Company Biosynex
Select your edition
All financial news and data tailored to specific country editions

















